Option Care Health's (OPCH) "Market Outperform" Rating Reaffirmed at JMP Securities

Option Care Health (NASDAQ:OPCH - Get Free Report)'s stock had its "market outperform" rating reaffirmed by stock analysts at JMP Securities in a research note issued to investors on Friday,Benzinga reports. They presently have a $30.00 price objective on the stock, down from their previous price objective of $31.00. JMP Securities' price target points to a potential upside of 25.05% from the company's previous close.

A number of other research analysts have also recently weighed in on the company. The Goldman Sachs Group cut Option Care Health from a "buy" rating to a "neutral" rating and reduced their target price for the company from $38.00 to $27.00 in a report on Monday, November 4th. Barrington Research reduced their target price on shares of Option Care Health from $40.00 to $32.00 and set an "outperform" rating on the stock in a report on Thursday, October 31st. Truist Financial lowered their price target on Option Care Health from $41.00 to $34.00 and set a "buy" rating for the company in a report on Friday, November 1st. UBS Group began coverage on Option Care Health in a research report on Thursday, December 5th. They issued a "neutral" rating and a $26.00 target price for the company. Finally, Bank of America downgraded Option Care Health from a "buy" rating to a "neutral" rating and dropped their target price for the company from $43.00 to $29.00 in a report on Wednesday, October 30th. Four analysts have rated the stock with a hold rating and three have given a buy rating to the company's stock. Based on data from MarketBeat, the company presently has an average rating of "Hold" and a consensus price target of $29.14.

Option Care Health Trading Down 0.6 %

Shares of OPCH traded down $0.15 during mid-day trading on Friday, hitting $23.99. The company had a trading volume of 1,842,414 shares, compared to its average volume of 1,480,236. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. The stock has a market cap of $4.08 billion, a PE ratio of 20.16, a P/E/G ratio of 2.43 and a beta of 1.31. Option Care Health has a 1-year low of $21.39 and a 1-year high of $34.63. The business's 50-day simple moving average is $23.10 and its 200-day simple moving average is $27.70.

Insider Activity

In other news, Director Harry M. Jansen Kraemer, Jr. purchased 43,000 shares of the stock in a transaction dated Friday, November 8th. The stock was acquired at an average cost of $22.54 per share, for a total transaction of $969,220.00. Following the acquisition, the director now owns 326,334 shares of the company's stock, valued at $7,355,568.36. The trade was a 15.18 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this link. Company insiders own 0.64% of the company's stock.

Hedge Funds Weigh In On Option Care Health

Several large investors have recently added to or reduced their stakes in the company. Westfield Capital Management Co. LP boosted its holdings in shares of Option Care Health by 10.2% in the 3rd quarter. Westfield Capital Management Co. LP now owns 6,492,152 shares of the company's stock valued at $203,204,000 after buying an additional 599,589 shares during the period. Global Alpha Capital Management Ltd. raised its position in shares of Option Care Health by 108.3% during the 3rd quarter. Global Alpha Capital Management Ltd. now owns 49,818 shares of the company's stock worth $1,559,000 after purchasing an additional 25,905 shares during the period. Victory Capital Management Inc. lifted its holdings in shares of Option Care Health by 4,432.8% in the 3rd quarter. Victory Capital Management Inc. now owns 1,621,593 shares of the company's stock worth $50,756,000 after purchasing an additional 1,585,818 shares during the last quarter. Edgestream Partners L.P. boosted its position in Option Care Health by 96.8% during the 2nd quarter. Edgestream Partners L.P. now owns 351,476 shares of the company's stock valued at $9,736,000 after purchasing an additional 172,845 shares during the period. Finally, Pier Capital LLC grew its stake in Option Care Health by 88.4% during the 3rd quarter. Pier Capital LLC now owns 231,884 shares of the company's stock worth $7,258,000 after buying an additional 108,783 shares during the last quarter. 98.05% of the stock is currently owned by institutional investors.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.